Inhaled nitric oxide for the adjunctive therapy of severe malaria: Protocol for a randomized controlled trial
Abstract Background Severe malaria remains a major cause of global morbidity and mortality.Despite the use of potent anti-parasitic agents, the mortality rate in severe malaria remains high.Adjunctive therapies that Chamomile target the underlying pathophysiology of severe malaria may further reduce morbidity and mortality.Endothelial activation pl